Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 10, 2017 08:00 ET | Source: Endocyte, Inc.

Endocyte Reports First Quarter Financial Results and Provides Clinical and Pipeline Update

WEST LAFAYETTE, Ind., May 10, 2017 (GLOBE NEWSWIRE) -- Endocyte, Inc. (NASDAQ:ECYT), a leader in developing targeted small molecule drug conjugates (SMDCs) and companion imaging agents for...
May 03, 2017 16:01 ET | Source: Endocyte, Inc.

Endocyte Announces First Quarter 2017 Earnings Conference Call

WEST LAFAYETTE, Ind., May 03, 2017 (GLOBE NEWSWIRE) -- Endocyte, Inc., (NASDAQ:ECYT) announced today that the company will host a conference call on Wednesday, May 10th, at 8:30 a.m. EDT to discuss...
April 05, 2017 08:00 ET | Source: Endocyte, Inc.

Endocyte Presents Data at AACR Identifying Multiple Methods for Managing Severe Side Effects Resulting from CAR T-Cell Treatment

- Late-breaking poster demonstrates that Endocyte’s bi-specific adaptor molecules can mitigate or eliminate cytokine storms - - Potential to meaningfully improve the safety and tolerability of CAR...
March 27, 2017 16:01 ET | Source: Endocyte, Inc.

Endocyte Announces Presentations at American Association for Cancer Research (AACR) Annual Meeting 2017

WEST LAFAYETTE, Ind., March 27, 2017 (GLOBE NEWSWIRE) -- Endocyte, Inc. (NASDAQ:ECYT), a leader in developing targeted small molecule drug conjugates (SMDCs) and companion imaging agents for...
March 10, 2017 08:05 ET | Source: Endocyte, Inc.

Endocyte Reports Fourth Quarter and Year End 2016 Financial Results and Provides Clinical and Pipeline Update

WEST LAFAYETTE, Ind., March 10, 2017 (GLOBE NEWSWIRE) -- Endocyte, Inc. (NASDAQ:ECYT), a leader in developing targeted small molecule drug conjugates (SMDCs) and companion imaging agents for...
March 10, 2017 08:00 ET | Source: Endocyte, Inc.

Endocyte and Seattle Children’s Research Institute to Collaborate on Endocyte’s Small Molecule Drug Conjugate Bi-Specific Adaptor Molecules for CAR T-cell Therapies

Collaboration pairs leading SMDC technology with recognized CAR T-cell research expert Plans to develop next generation CAR T-cell therapeutic platform with potential for improved safety and...
March 02, 2017 08:00 ET | Source: Endocyte, Inc.

Endocyte Announces Fourth Quarter and Full Year 2016 Earnings Conference Call

WEST LAFAYETTE, Ind., March 02, 2017 (GLOBE NEWSWIRE) -- Endocyte, Inc., (NASDAQ:ECYT) announced today that the company will host a conference call on Friday, March 10th, at 8:30 a.m. EST to discuss...
March 01, 2017 16:01 ET | Source: Endocyte, Inc.

Endocyte to Present at the Cowen and Company 37th Annual Health Care Conference

WEST LAFAYETTE, Ind., March 01, 2017 (GLOBE NEWSWIRE) -- Endocyte, Inc. (NASDAQ:ECYT), a leader in developing targeted small molecule drug conjugates (SMDCs) and companion imaging agents for...
February 21, 2017 08:00 ET | Source: Endocyte, Inc.

Endocyte Appoints Michael T. Andriole as Chief Financial Officer

WEST LAFAYETTE, Ind., Feb. 21, 2017 (GLOBE NEWSWIRE) -- Endocyte, Inc. (NASDAQ:ECYT), a leader in developing targeted small molecule drug conjugates (SMDCs) and companion imaging agents for...
December 01, 2016 08:01 ET | Source: Endocyte, inc

Endocyte to Present at the IASLC 17th World Conference on Lung Cancer

WEST LAFAYETTE, Ind., Dec. 01, 2016 (GLOBE NEWSWIRE) -- Endocyte, Inc. (NASDAQ:ECYT), a leader in developing targeted small molecule drug conjugates (SMDCs) and companion imaging agents for...